1 | exclusion | 3,016 |
2 | eligibility | 3,004 |
3 | terminology | 412 |
4 | licensure | 122 |
5 | beers | 89 |
6 | prentice | 43 |
7 | choi | 40 |
8 | dangerousness | 34 |
9 | invasibility | 19 |
10 | stopp/start | 18 |
11 | acr/eular | 16 |
12 | coustan | 12 |
13 | lung-rads | 12 |
14 | oxman | 12 |
15 | mcgeer | 10 |
16 | barkhof | 9 |
17 | poser | 9 |
18 | robertson | 9 |
19 | admissibility | 7 |
20 | inclusionary | 7 |
21 | lavin-osband | 7 |
22 | loeb | 7 |
23 | paradise | 7 |
24 | wolfson | 7 |
25 | h14 | 6 |
26 | ipm-qrb | 6 |
27 | noninclusion | 6 |
28 | kales | 5 |
29 | rome-iii | 5 |
30 | inclusion-exclusion | 4 |
31 | rajka | 4 |
32 | tmtmr | 4 |
33 | alexopoulos | 3 |
34 | dsm/icd | 3 |
35 | prifle | 3 |
36 | reinhold | 3 |
37 | 'paradise | 2 |
38 | atp-ncep-iii | 2 |
39 | caoshanhu | 2 |
40 | clnical | 2 |
41 | concha-containing | 2 |
42 | decolourisation | 2 |
43 | discontinuances | 2 |
44 | eligiblity | 2 |
45 | esur/pi-rads | 2 |
46 | female-age | 2 |
47 | gallamini | 2 |
48 | gubner-ungerleider | 2 |
49 | keswick | 2 |
50 | sorting/ranking | 2 |
51 | studies.selection | 2 |
52 | tel-hashomer | 2 |
53 | trials.selection | 2 |
54 | δsraw-based | 2 |
55 | acosog/z011 | 1 |
56 | acupuncture.inclusion | 1 |
57 | adherenceassurance | 1 |
58 | age-exclusion | 1 |
59 | aha/ase | 1 |
60 | amsela | 1 |
61 | anvisa/brazil | 1 |
62 | bmi-selective | 1 |
63 | boolean-based | 1 |
64 | burkus | 1 |
65 | case-inclusion | 1 |
66 | clinicogenetic | 1 |
67 | consort/strobe | 1 |
68 | detail-oriented | 1 |
69 | doesn´t | 1 |
70 | dsmiv-tr | 1 |
71 | early-improvement | 1 |
72 | ecg-mi | 1 |
73 | evidence-grading | 1 |
74 | excess-pcos | 1 |
75 | failure/mismatch | 1 |
76 | fiberoptically | 1 |
77 | fit-to-discharge | 1 |
78 | flos-containing | 1 |
79 | gcig-ca125 | 1 |
80 | gender.quality | 1 |
81 | group.assessment | 1 |
82 | histology-correlated | 1 |
83 | icm-10 | 1 |
84 | identifications-met | 1 |
85 | in-/exclusion | 1 |
86 | inclusion/entry | 1 |
87 | inclusive/exclusive | 1 |
88 | information.selection | 1 |
89 | merchant-dietz | 1 |
90 | microcirculation-sensitive | 1 |
91 | miscontrol | 1 |
92 | more-reliable | 1 |
93 | nai-aa | 1 |
94 | novacode | 1 |
95 | oberholtzer | 1 |
96 | participant-defined | 1 |
97 | perkeni | 1 |
98 | prespecifed | 1 |
99 | re-defining | 1 |
100 | rheumatology-90 | 1 |
101 | schedule-2 | 1 |
102 | self-making | 1 |
103 | study-reporting | 1 |
104 | sweden.inclusion | 1 |
105 | text-revision | 1 |
106 | therapist-blinding | 1 |
107 | trial.inclusion | 1 |
108 | up-to-seven | 1 |
109 | who-monica | 1 |
110 | women.inclusion | 1 |
111 | •toronto | 1 |
1 | 'paradise | 2 |
2 | acosog/z011 | 1 |
3 | acr/eular | 16 |
4 | acupuncture.inclusion | 1 |
5 | adherenceassurance | 1 |
6 | admissibility | 7 |
7 | age-exclusion | 1 |
8 | aha/ase | 1 |
9 | alexopoulos | 3 |
10 | amsela | 1 |
11 | anvisa/brazil | 1 |
12 | atp-ncep-iii | 2 |
13 | barkhof | 9 |
14 | beers | 89 |
15 | bmi-selective | 1 |
16 | boolean-based | 1 |
17 | burkus | 1 |
18 | caoshanhu | 2 |
19 | case-inclusion | 1 |
20 | choi | 40 |
21 | clinicogenetic | 1 |
22 | clnical | 2 |
23 | concha-containing | 2 |
24 | consort/strobe | 1 |
25 | coustan | 12 |
26 | dangerousness | 34 |
27 | decolourisation | 2 |
28 | detail-oriented | 1 |
29 | discontinuances | 2 |
30 | doesn´t | 1 |
31 | dsm/icd | 3 |
32 | dsmiv-tr | 1 |
33 | early-improvement | 1 |
34 | ecg-mi | 1 |
35 | eligibility | 3,004 |
36 | eligiblity | 2 |
37 | esur/pi-rads | 2 |
38 | evidence-grading | 1 |
39 | excess-pcos | 1 |
40 | exclusion | 3,016 |
41 | failure/mismatch | 1 |
42 | female-age | 2 |
43 | fiberoptically | 1 |
44 | fit-to-discharge | 1 |
45 | flos-containing | 1 |
46 | gallamini | 2 |
47 | gcig-ca125 | 1 |
48 | gender.quality | 1 |
49 | group.assessment | 1 |
50 | gubner-ungerleider | 2 |
51 | h14 | 6 |
52 | histology-correlated | 1 |
53 | icm-10 | 1 |
54 | identifications-met | 1 |
55 | in-/exclusion | 1 |
56 | inclusion-exclusion | 4 |
57 | inclusion/entry | 1 |
58 | inclusionary | 7 |
59 | inclusive/exclusive | 1 |
60 | information.selection | 1 |
61 | invasibility | 19 |
62 | ipm-qrb | 6 |
63 | kales | 5 |
64 | keswick | 2 |
65 | lavin-osband | 7 |
66 | licensure | 122 |
67 | loeb | 7 |
68 | lung-rads | 12 |
69 | mcgeer | 10 |
70 | merchant-dietz | 1 |
71 | microcirculation-sensitive | 1 |
72 | miscontrol | 1 |
73 | more-reliable | 1 |
74 | nai-aa | 1 |
75 | noninclusion | 6 |
76 | novacode | 1 |
77 | oberholtzer | 1 |
78 | oxman | 12 |
79 | paradise | 7 |
80 | participant-defined | 1 |
81 | perkeni | 1 |
82 | poser | 9 |
83 | prentice | 43 |
84 | prespecifed | 1 |
85 | prifle | 3 |
86 | rajka | 4 |
87 | re-defining | 1 |
88 | reinhold | 3 |
89 | rheumatology-90 | 1 |
90 | robertson | 9 |
91 | rome-iii | 5 |
92 | schedule-2 | 1 |
93 | self-making | 1 |
94 | sorting/ranking | 2 |
95 | stopp/start | 18 |
96 | studies.selection | 2 |
97 | study-reporting | 1 |
98 | sweden.inclusion | 1 |
99 | tel-hashomer | 2 |
100 | terminology | 412 |
101 | text-revision | 1 |
102 | therapist-blinding | 1 |
103 | tmtmr | 4 |
104 | trial.inclusion | 1 |
105 | trials.selection | 2 |
106 | up-to-seven | 1 |
107 | who-monica | 1 |
108 | wolfson | 7 |
109 | women.inclusion | 1 |
110 | δsraw-based | 2 |
111 | •toronto | 1 |
1 | icm-10 | 1 |
2 | rheumatology-90 | 1 |
3 | acosog/z011 | 1 |
4 | schedule-2 | 1 |
5 | h14 | 6 |
6 | gcig-ca125 | 1 |
7 | nai-aa | 1 |
8 | who-monica | 1 |
9 | rajka | 4 |
10 | amsela | 1 |
11 | loeb | 7 |
12 | ipm-qrb | 6 |
13 | clinicogenetic | 1 |
14 | dsm/icd | 3 |
15 | prespecifed | 1 |
16 | participant-defined | 1 |
17 | boolean-based | 1 |
18 | δsraw-based | 2 |
19 | histology-correlated | 1 |
20 | detail-oriented | 1 |
21 | reinhold | 3 |
22 | lavin-osband | 7 |
23 | consort/strobe | 1 |
24 | prentice | 43 |
25 | adherenceassurance | 1 |
26 | novacode | 1 |
27 | female-age | 2 |
28 | fit-to-discharge | 1 |
29 | more-reliable | 1 |
30 | prifle | 3 |
31 | licensure | 122 |
32 | aha/ase | 1 |
33 | paradise | 7 |
34 | 'paradise | 2 |
35 | inclusive/exclusive | 1 |
36 | bmi-selective | 1 |
37 | microcirculation-sensitive | 1 |
38 | barkhof | 9 |
39 | evidence-grading | 1 |
40 | therapist-blinding | 1 |
41 | self-making | 1 |
42 | sorting/ranking | 2 |
43 | concha-containing | 2 |
44 | flos-containing | 1 |
45 | re-defining | 1 |
46 | study-reporting | 1 |
47 | failure/mismatch | 1 |
48 | rome-iii | 5 |
49 | atp-ncep-iii | 2 |
50 | ecg-mi | 1 |
51 | perkeni | 1 |
52 | gallamini | 2 |
53 | choi | 40 |
54 | keswick | 2 |
55 | clnical | 2 |
56 | anvisa/brazil | 1 |
57 | miscontrol | 1 |
58 | oxman | 12 |
59 | coustan | 12 |
60 | up-to-seven | 1 |
61 | text-revision | 1 |
62 | case-inclusion | 1 |
63 | acupuncture.inclusion | 1 |
64 | trial.inclusion | 1 |
65 | sweden.inclusion | 1 |
66 | women.inclusion | 1 |
67 | noninclusion | 6 |
68 | exclusion | 3,016 |
69 | age-exclusion | 1 |
70 | inclusion-exclusion | 4 |
71 | in-/exclusion | 1 |
72 | decolourisation | 2 |
73 | information.selection | 1 |
74 | studies.selection | 2 |
75 | trials.selection | 2 |
76 | wolfson | 7 |
77 | robertson | 9 |
78 | •toronto | 1 |
79 | acr/eular | 16 |
80 | gubner-ungerleider | 2 |
81 | mcgeer | 10 |
82 | tel-hashomer | 2 |
83 | poser | 9 |
84 | oberholtzer | 1 |
85 | tmtmr | 4 |
86 | dsmiv-tr | 1 |
87 | lung-rads | 12 |
88 | esur/pi-rads | 2 |
89 | discontinuances | 2 |
90 | kales | 5 |
91 | excess-pcos | 1 |
92 | alexopoulos | 3 |
93 | beers | 89 |
94 | dangerousness | 34 |
95 | burkus | 1 |
96 | identifications-met | 1 |
97 | early-improvement | 1 |
98 | group.assessment | 1 |
99 | stopp/start | 18 |
100 | doesn´t | 1 |
101 | caoshanhu | 2 |
102 | terminology | 412 |
103 | fiberoptically | 1 |
104 | inclusionary | 7 |
105 | inclusion/entry | 1 |
106 | gender.quality | 1 |
107 | eligiblity | 2 |
108 | eligibility | 3,004 |
109 | invasibility | 19 |
110 | admissibility | 7 |
111 | merchant-dietz | 1 |